More recently, the same group used this model to identity liquid biomarkers that may be useful in assessing the AKI to CKD transition, with urinary insulin growth factor like binding protein‐3 (IGFBP‐3) and soluble tumor necrosis factor receptor II (sTNFRII) measured at time of AKI predicting structural findings on CFE‐MRI and histology at 12‐weeks.88 The gene discussed is IGFBP3; the disease is acute kidney injury.